Ethics in Clinical Trials South African Perspective

Section 72 of the National Health Act establishes the regulatory framework for health research in South Africa, emphasizing the importance of ethical standards and guidelines. This section mandates that the National Department of Health (NDOH) adhere to specific ethical principles, making the NDOH Ethics in Health Research Guidelines (2024) the minimum benchmark for conducting health research. By ensuring compliance with these guidelines, the legislation aims to protect participants' rights and promote ethical practices in health research across the country.

In South Africa, the regulatory framework mandates that SAHPRA scientific approval must be secured prior to finalizing ethics approval for clinical trials. This sequence ensures that the scientific merit and safety of the trial are evaluated by SAHPRA, which is crucial for protecting participants and ensuring compliance with national standards. By obtaining SAHPRA approval first, researchers can address any scientific concerns that may arise, allowing ethics committees to make informed decisions regarding the ethical aspects of the trial. This process promotes thorough oversight and enhances the integrity of clinical research.

ICH GCP E6(R3) streamlined its core principles from 13 to 11 to enhance clarity and focus on essential aspects of Good Clinical Practice. This reduction aims to simplify the guidelines, making them more accessible and easier to implement for stakeholders in clinical trials. By consolidating principles, the ICH seeks to promote better compliance and understanding, ultimately improving the quality and integrity of clinical research while ensuring the protection of trial participants.

Under the Protection of Personal Information Act (POPIA), data is deemed 'not personal information' when it has been permanently anonymised, meaning it cannot be traced back to an individual. This ensures that privacy is maintained, as the data cannot be linked to any identifiable person. Anonymisation is a key process in data protection, allowing organizations to use data for analysis without compromising individual privacy rights. If data can still be linked to an individual, it remains classified as personal information and is subject to the protections outlined in POPIA.

Research Ethics Committees (RECs) in South Africa are mandated to ensure diverse and balanced representation. Having at least 9 members allows for a variety of perspectives, while including experts in ethics and law ensures informed decision-making. Community representatives are essential for reflecting public interests and values. The gender balance requirement of no more than 70% of either gender promotes inclusivity and prevents dominance by one group, fostering a more equitable approach to ethical review in research.

The 9th edition of the Declaration of Helsinki emphasizes the ethical obligation of researchers and sponsors to ensure that participants who have benefited from investigational medications during a trial continue to have access to these treatments post-trial. This update reflects a commitment to participant welfare and recognizes the importance of safeguarding the health of individuals who contributed to clinical research, thereby enhancing ethical standards in medical research and promoting accountability among researchers and sponsors.

In the context of clinical research and ethical standards, South African Good Clinical Practice (SA GCP) guidelines are specifically tailored to address the legal and cultural context of South Africa. When conflicts arise between these national guidelines and international standards, SA GCP takes precedence to ensure that local ethical considerations, legal requirements, and community values are prioritized. This approach helps protect the rights and welfare of participants within South Africa, reflecting the country's commitment to ethical research practices that align with its unique social landscape.

POPIA mandates that participants in clinical trials must give informed consent regarding the use of their personal data, ensuring transparency and autonomy. Data Transfer Agreements are essential for legally sharing patient information across borders, safeguarding data integrity and privacy. Furthermore, storing unencrypted data breaches POPIA's security provisions, highlighting the importance of data protection measures. Additionally, due to the sensitive nature of HIV status, POPIA stipulates enhanced protection for this information, recognizing the heightened risks associated with its disclosure. These requirements collectively aim to protect individuals’ privacy and ensure compliance with data protection laws.